Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank86
3Y CAGR+1.7%
5Y CAGR+2.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+1.7%/yr
vs -1.4%/yr prior
5Y CAGR
+2.9%/yr
Consistent
Acceleration
+3.1pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $40.65M | +7.8% |
| 2024 | $37.71M | -12.4% |
| 2023 | $43.04M | +11.5% |
| 2022 | $38.60M | +10.7% |
| 2021 | $34.85M | -0.9% |
| 2020 | $35.17M | -3.0% |
| 2019 | $36.26M | -11.0% |
| 2018 | $40.75M | +7.6% |
| 2017 | $37.86M | +32.8% |
| 2016 | $28.50M | - |